Akynzeo 300-0.5 MG capsules
Ended Awarded
- Contract number
- SPE2DR26F9BE0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $67,366
Award facts
- Contract value 100% obligated
- $67,365.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $67,365.65 delivery order to AmerisourceBergen Drug Corp for AKYNZEO 300-0.5 mg capsules, a pharmaceutical product used to prevent chemotherapy-induced nausea and vomiting. This firm fixed price contract, awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical.
This award exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains a substantial IDC with DLA valued at $999,999,999.00 through December 2026, which serves as the primary vehicle enabling the delivery of comprehensive pharmaceutical products and medical supplies to support defense health programs globally. AmerisourceBergen's federal contracting history demonstrates consistent capability in competitively awarded pharmaceutical supply contracts with the Defense Logistics Agency, serving entities including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9BE0?
SPE2DR26F9BE0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26F9BE0 worth?
The government has obligated $67,366 on SPE2DR26F9BE0.
Is contract SPE2DR26F9BE0 an order under another contract?
Yes. SPE2DR26F9BE0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BE0 competed?
The extent of competition for SPE2DR26F9BE0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award